Scientific and Technical Council of the State Corporation "Rosatom": "Nuclear Medicine and Radiation Biology". Prospects for the use of biological means of radiation protection

24.06.2019 Comments (0) news  Like

17 June 2019 the representatives of the company RETSIS participated in the work of the State Corporation "Rosatom" Scientific and Technical Council: "Nuclear Medicine and Radiation Biology". Scientific papers were presented on the topic: "The development and use of biological means of radiation protection. Status and Prospects ".

RETSIS company actively cooperates with specialists from the Moscow State Academy of Veterinary Medicine and Biotechnology. KI. Scryabin, conducts joint research projects in the field of veterinary medicine and radiology. At the meeting in the "Rosatom" I received a report of Nikolai Petrovich Lysenko, head of the department they MVA. KI. Scryabin, Doctor of Biological Sciences: "Enhancement of radiation resistance of the animal organism when used sorbents and radioprotective agents of natural origin".

Scientific and Technical Council (NTS) State Corporation "Rosatom" permanent consultative and advisory body, designed for carrying out scientific and technical expertise to ensure sustainable growth of nuclear energy complex, improve radiation safety, the development of basic and applied research and technological development in the field of radiology.

At a meeting of the Board of the reports as the same were made by scientists from FGBU "NMITS Radiology" Ministry of Health of Russia, «MRNC» them. AF. Tsyba, Center "Kurchatov Institute".

The discussion papers NTS State Corporation "Rosatom" has decided to recognize the results achieved successful, promising direction of research, social and economic importance to minimize the risk of occupational diseases specialists of nuclear facilities, health workers X-ray radiological Profile, reduce the effects of radiation exposure to humans and pets. The Council decided to include in the research plan of "Rosatom" pre-clinical trials of new drugs - radiation protectors, developed at the Department of Radiobiology MVA E. KI. Scryabin.

The subsequent transfer of new drugs in the health facilities will serve for further use as a means of radiation protection of nuclear objects and people, professionally associated with exposure to ionizing radiation.